Clemastine Treatment in Individuals With Williams Syndrome

Summary

This study explores the neurobiological etiology of Williams syndrome and potential therapeutic targets for associated social, motor, and cognitive abnormalities. The main translational objective will be to test the effectiveness of Clemasntine on neurocognitive and other associated abnormalities in individuals with Williams syndrome.

Timeline

Start

2024-04-01

Primary completion

2026-05

Completion

2026-07

Drugs

Indications